Palbociclib, Trastuzumab,Pyrotinib and Fulvestrant Treatment in Patients With Brain Metastasis From ER/PR Positive, HER-2 Positive Breast Cancer: A Multi-center, Prospective Study in China
Clinical trial NCT04334330 · UNKNOWN
Trial details
- NCT number
- NCT04334330
- Sponsor
- Sun Yat-sen University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-04
- Primary completion
- 2023-12-30
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.